BGSI
Boyd Group Services Inc.
BGSI has the edge over LCID overall, supported by lower modeled downside and stronger fundamentals.
LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BGSI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Weak |
BGSI's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BGSI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $74.46 | — |
| Cheap | 119x | $56.01 | -25% |
| Fair | 142x | $66.59 | -11% |
| Current | 160x | $74.46 | — |
| Expensive | 171x | $80.22 | +7.7% |
Historical ranges are pointers, not guarantees.
BGSI's PE is 160x, but its earnings don't support one, so it isn't a reliable read right now.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BGSI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BGSI, with profitability holding steady. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BGSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.96 | +743% |
| Q2 2026 | $0.47 | +27% |
| Q1 2026 | $0.67 | +8.1% |
| Q4 2025 | $0.83 | -27% |
| Q3 2025 | $0.74 | -61% |
BGSI has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BGSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1B | +30% |
| Q1 2026 | $982.9M | +26% |
| Q4 2025 | $793.9M | +5.5% |
| Q3 2025 | $790.2M | +5% |
| Q2 2025 | $780.4M | +0.2% |
| Q1 2025 | $778.3M | -1% |
| Q4 2024 | $752.3M | +1.7% |
BGSI's revenue has grown year over year for five quarters in a row: $1B last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | +9.1 points |
| Q1 2026 | 4.1% | +1.4 points |
| Q4 2025 | 5.1% | +1.9 points |
| Q3 2025 | 4.7% | +1.7 points |
| Q2 2025 | 4.3% | 0 points |
| Q1 2025 | 2.8% | -7.6 points |
| Q4 2024 | 3.2% | -9.5 points |
| Q3 2024 | 3% | N/A |
BGSI has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BGSI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BGSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $88.3M | +1.1% |
| Q1 2026 | $96M | +77% |
| Q4 2025 | $62.1M | -1.9% |
| Q3 2025 | $83.7M | +77% |
| Q2 2025 | $87.4M | +45% |
| Q1 2025 | $54.3M | -13% |
| Q4 2024 | $63.2M | -25% |
BGSI has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BGSI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +68.3K shares |
| 1 year | +30% | +6.4M shares |
BGSI has 28M diluted shares, up 30% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BGSI hasn't bought back shares in the past year.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over BGSI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BGSI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.8x | High |
| Q1 2026 | 5.4x | High |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.9x | Elevated |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 4.1x | High |
| Q3 2024 | 4.3x | High |
BGSI's net debt is about 4.8 years of its operating earnings (EBITDA), up from 3.9 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BGSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.6 | Neutral |
| Stochastic | 21.0 | Neutral |
BGSI's weekly RSI is 33 (neutral) and its Stochastic is 21 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BGSI PE vs Consumer Cyclical Sector
| Metric | BGSI | Sector median | Relative |
|---|---|---|---|
| PE | 160x | 18x | 786% above |
| PE % | 81 | 13 | 68 pts above |
BGSI is trading at 160x earnings, a 786% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BGSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.8 | 7.9% below |
| 20 week MA | $89.3 | 17% below |
| 50 week MA | $119.2 | 38% below |
LCID has stronger trend alignment. BGSI is above 0 of 3 weekly averages versus LCID above 0 of 5.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BGSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $153.5 | $163.1 | +6.2% |
| 2026 YTD | $163.1 | $74.5 | -54% |
BGSI has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.